Familial dilated cardiomyopathy: another risk factor for anthracycline-induced cardiotoxicity?
van den Berg
Maarten P
MP
Department of Cardiology, University Medical Center Groningen, University of Groningen, PO Box 30.001, 9700 RB Groningen, The Netherlands. m.p.van.den.berg@thorax.umcg.nl
van Spaendonck-Zwarts
Karin Y
KY
van Veldhuisen
Dirk J
DJ
Gietema
Jourik A
JA
Postma
Aleida
A
van Tintelen
J Peter
JP
D000328:Adult; D018943:Anthracyclines / Q000009:adverse effects; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects*; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced / Q000235:genetics; D054715:Cardiotoxins; D003630:Daunorubicin / Q000009:adverse effects*; D004317:Doxorubicin / Q000009:adverse effects*; D020022:Genetic Predisposition to Disease; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy; D012307:Risk Factors; D018487:Ventricular Dysfunction, Left / Q000139:chemically induced* / Q000235:genetics; D016277:Ventricular Function, Left / Q000187:drug effects
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D054715:Cardiotoxins; D004317:Doxorubicin; D003630:Daunorubicin